Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 32004R2232

    Commission Regulation (EC) No 2232/2004 of 23 December 2004 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards altrenogest, beclomethasone dipropionate, cloprostenol, r-cloprostenol, sorbitan sesquioleate and toltrazurilText with EEA relevance

    OJ L 379, 24.12.2004, p. 71–74 (ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
    OJ L 348M, 24.12.2008, p. 30–33 (MT)

    ⏵This document has been published in a special edition(s) (BG, RO)

    Legal status of the document No longer in force, Date of end of validity: 05/07/2009; Implicitly repealed by 32009R0470

    ELI: http://data.europa.eu/eli/reg/2004/2232/oj

    Date of document:
    23/12/2004
    Date of effect:
    27/12/2004; Entry into force See Art 2
    Date of effect:
    22/02/2005; Application See Art 2
    Date of end of validity:
    05/07/2009; Implicitly repealed by 32009R0470
    Author:
    European Commission
    Form:
    Regulation
    Additional information:
    Extended to the EEA by 22005D0098, EEA relevance
    Authentic language:
    Spanish, Czech, Danish, German, Estonian, Greek, English, French, Italian, Latvian, Lithuanian, Hungarian, Maltese, Dutch, Polish, Portuguese, Slovak, Slovenian, Finnish, Swedish, Icelandic, Norwegian
    Treaty:
    Treaty establishing the European Community
    Legal basis:
    Link
    Link
    Link
    Select all documents mentioning this document
    Modifies:
    Relation Act Comment Subdivision concerned From To
    Modifies 31990R2377 Amendment annex 2 22/02/2005
    Modifies 31990R2377 Amendment annex 3 22/02/2005
    Modifies 31990R2377 Amendment annex 1 22/02/2005
    Modified by:
    Relation Act Comment Subdivision concerned From To
    Corrected by 32004R2232R(01) (MT)
    Implicitly repealed by 32009R0470 06/07/2009
    Instruments cited:
    Link
    Link

    24.12.2004   

    EN

    Official Journal of the European Union

    L 379/71

    COMMISSION REGULATION (EC) No 2232/2004

    of 23 December 2004

    amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards altrenogest, beclomethasone dipropionate, cloprostenol, r-cloprostenol, sorbitan sesquioleate and toltrazuril

    (Text with EEA relevance)

    THE COMMISSION OF THE EUROPEAN COMMUNITIES,

    Having regard to the Treaty establishing the European Community,

    Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), and in particular Articles 2 and 3 and the third paragraph of Article 4 thereof,

    Having regard to the opinions of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use,

    Whereas:

    (1)

    All pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals should be evaluated in accordance with Regulation (EEC) No 2377/90.

    (2)

    The substance altrenogest was included, in accordance with Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC (2), in Annex III to Regulation (EEC) No 2377/90 for porcine species and equidae for zootechnical use only pending completion of scientific studies. These studies have now been completed and altrenogest should therefore be inserted in Annex I to that Regulation.

    (3)

    The substance beclomethasone dipropionate should be included in Annex II to Regulation (EEC) No 2377/90 for equidae but only for inhalation use.

    (4)

    The substances cloprostenol and r-cloprostenol have been included in Annex II to Regulation (EEC) No 2377/90 for bovine, porcine and equine species. Those entries should be extended to cover caprine species.

    (5)

    The substance sorbitan sesquioleate is closely related to sorbitan trioleate, which is included in Annex II to Regulation (EEC) No 2377/90 for all food producing species. Other sorbitan esters are authorised as food additives under Directive 95/2/EC of the European Parliament and Council of 20 February 1995 on food additives other than colours and sweeteners (3) and are therefore included in Annex II to Regulation (EEC) No 2377/90 for all food producing species. The sorbitan esters concerned are sorbitan monostearate (E491), sorbitan tristearate (E492), sorbitan monolaurate (E493), sorbitan monooleate (E494) and sorbitan monopalmitate (E495). sorbitan sesquioleate should therefore also be included in that Annex II for all food producing species.

    (6)

    The substance toltrazuril is included in Annex I to Regulation (EEC) No 2377/90 for chickens, turkeys, and porcine species. In order to allow for the completion of scientific studies for the extension to cover bovine species, toltrazuril should be included in Annex III to that Regulation, but not for animals from which milk is produced for human consumption.

    (7)

    Regulation (EEC) No 2377/90 should be amended accordingly.

    (8)

    An adequate period should be allowed before the applicability of this Regulation in order to enable Member States to make any adjustment which may be necessary in the light of this Regulation to the marketing authorisations granted in accordance with Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products (4).

    (9)

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

    HAS ADOPTED THIS REGULATION:

    Article 1

    Annexes I, II and III to Regulation (EEC) No 2377/90 are amended in accordance with the Annex to this Regulation.

    Article 2

    This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Union.

    It shall apply from 22 February 2005.

    This Regulation shall be binding in its entirety and directly applicable in all Member States.

    Done at Brussels, 23 December 2004.

    For the Commission

    Günter VERHEUGEN

    Vice-President

    (1)   OJ L 224, 18.8.1990, p. 1. Regulation as last amended by Commission Regulation (EC) No 1875/2004 (OJ L 326, 29.10.2004, p. 19).

    (2)   OJ L 125, 23.5.1996, p. 3. Directive as last amended by Directive 2003/74/EC of the European Parliament and of the Council (OJ L 262, 14.10.2003, p. 17).

    (3)   OJ L 61, 18.3.1995, p. 1. Directive as last amended by Regulation (EC) No 1882/2003 (OJ L 284, 31.10.2003, p. 1).

    (4)   OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive 2004/28/EC (OJ L 136, 30.4.2004, p. 58).

    ANNEX

    A.   The following substance(s) is(are) inserted in Annex I to Regulation (EEC) No 2377/90

    6.   Agents acting on the reproductive system

    6.1.   Progestagens

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    ‘Altrenogest  (1)

    Altrenogest

    Porcine

    1  μg/kg

    Skin and fat

    0,4  μg/kg

    Liver

    Equidae

    1  μg/kg

    Fat

    0,9  μg/kg

    Liver’

    B.   The following substance(s) is(are) inserted in Annex II to Regulation (EEC) No 2377/90

    2.   Organic compounds

    Pharmacologically active substance(s)

    Animal species

    ‘Beclomethasone dipropionate

    Equidae (2)

    Cloprostenol

    Caprine

    R-cloprostenol

    Caprine

    Sorbitan sesquioleate

    All food producing species’

    C.   The following substance(s) is(are) inserted in Annex III to Regulation (EEC) No 2377/90

    2.   Antiparasitic agents

    2.4.   Agents acting against protozoa

    2.4.3.   Triazinetrione derivatives

    Pharmacologically active substance(s)

    Marker residue

    Animal species

    MRLs

    Target tissues

    ‘Toltrazuril  (3)

    Toltrazuril sulfone

    Bovine

    100  μg/kg

    Muscle

    150  μg/kg

    Fat

    500  μg/kg

    Liver

    250  μg/kg

    Kidney’

    (1)  Only for zootechnical use and in accordance with the provisions of Directive 96/22/EC.

    (2)  For inhalation use only.

    (3)  Provisional MRLs expire on 1 July 2006. Not for use in animals from which milk is produced for human consumption.

    Top